Danilo Casimiro
13Patents
5h-index
44Co-inventors
66Inventor score
Filing activity: Mar 27, 2001 → Nov 7, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8168757B2 | PD-1 binding proteins | Chemistry; Metallurgy | 319 | Active |
| US11752206B2 | Herpes simplex virus vaccine | Emerging Cross-Sectional Technologies | 17 | Active |
| US6787351B2 | Adenovirus carrying gag gene HIV vaccine | Chemistry; Metallurgy | 15 | Expired |
| US6733993B2 | Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications | Chemistry; Metallurgy | 15 | Expired |
| US7709010B2 | Papillomavirus vaccine compositions | Chemistry; Metallurgy | 6 | Active |
| US11771652B2 | Lipid nanoparticles for delivering mRNA vaccines | Human Necessities | 2 | Active |
| US11771653B2 | Lipid nanoparticles for delivering mRNA vaccines | Human Necessities | 2 | Active |
| US10449243B2 | Dengue virus vaccine compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12168047B2 | Tuberculosis antigen cassettes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11638749B2 | Tuberculosis antigen cassettes | Emerging Cross-Sectional Technologies | 0 | Active |
| US10821175B2 | Lipid nanoparticle vaccine adjuvants and antigen delivery systems | Emerging Cross-Sectional Technologies | 0 | Active |
| US11406706B2 | Lipid nanoparticle vaccine adjuvants and antigen delivery systems | Emerging Cross-Sectional Technologies | 0 | Active |
| US12239735B2 | Lipid nanoparticles for delivering mRNA vaccines | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.